Biogen issues $1.75B in three tranches of senior notes to refinance maturing 2025 debt

BIOGEN INC.

$400M 5.050% notes due 2031, $650M 5.750% notes due 2035, $700M 6.450% notes due 2055.
Net proceeds, with cash on hand, will retire the outstanding $1.75B 4.050% Senior Notes due 2025.
Notes are senior unsecured; redeemable at par plus make-whole; 101% change-of-control put.
Underwriters: BofA Securities, Citigroup Global Markets, J.P. Morgan Securities.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.